Largest Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
3692 Hansoh Pharmaceutical Group	HK$18.70	-3.7%	24.3%	HK$111.0b	HK$23.72	PE22x	E6.6%	2.1%
2269 WuXi Biologics (Cayman)	HK$23.30	-1.1%	44.9%	HK$95.5b	HK$22.66	PE33.8x	E16.5%	n/a
1801 Innovent Biologics	HK$39.30	-2.6%	-5.0%	HK$64.4b	HK$53.54	PS8.1x	E44.0%	n/a
9926 Akeso	HK$70.80	-1.5%	38.3%	HK$63.5b	HK$77.61	PS31.6x	E78.3%	n/a
1177 Sino Biopharmaceutical	HK$3.47	4.5%	5.2%	HK$63.1b	HK$4.51	PE27.5x	E12.9%	1.7%
1093 CSPC Pharmaceutical Group	HK$4.73	-2.7%	-28.0%	HK$54.4b	HK$6.93	PE9.8x	E2.3%	6.7%
6990 Sichuan Kelun-Biotech Biopharmaceutical	HK$238.00	-5.4%	54.7%	HK$54.1b	HK$228.50	PS26.9x	E5.4%	n/a
2268 WuXi XDC Cayman	HK$35.05	0.7%	116.4%	HK$42.0b	HK$37.86	PE65.9x	E27.9%	n/a
3320 China Resources Pharmaceutical Group	HK$5.40	0.7%	5.5%	HK$33.9b	HK$7.21	PE8.4x	E6.7%	3.3%
3933 United Laboratories International Holdings	HK$15.02	3.4%	77.3%	HK$27.3b	HK$12.14	PE8.8x	E4.6%	4.0%
1548 Genscript Biotech	HK$12.44	-3.1%	-25.6%	HK$26.7b	HK$21.97	PS5.8x	E73.2%	0%
1877 Shanghai Junshi Biosciences	HK$13.90	-7.7%	17.4%	HK$26.5b	HK$15.69	PS7.1x	E44.8%	n/a
2228 XtalPi Holdings	HK$6.57	-4.1%	n/a	HK$22.4b	HK$9.25	PS105.9x	E87.6%	n/a
512 Grand Pharmaceutical Group	HK$6.27	19.0%	72.7%	HK$22.0b	HK$6.63	PE8.9x	E-0.5%	4.1%
1530 3SBio	HK$9.03	20.4%	70.1%	HK$21.3b	HK$8.64	PE12x	E15.9%	2.7%
867 China Medical System Holdings	HK$8.48	6.5%	-32.5%	HK$20.5b	HK$10.95	PE13.7x	E21.4%	5.0%
2096 Simcere Pharmaceutical Group	HK$7.81	-2.0%	47.4%	HK$19.4b	HK$9.73	PS2.8x	E77.5%	2.2%
9969 InnoCare Pharma	HK$8.73	-9.7%	67.9%	HK$18.1b	HK$8.73	PS15.9x	E23.2%	n/a
1952 Everest Medicines	HK$51.45	2.0%	86.8%	HK$16.6b	HK$39.83	PS36.9x	E90.8%	n/a
2696 Shanghai Henlius Biotech	HK$29.10	-7.5%	95.6%	HK$15.8b	HK$24.59	PE21.3x	S9.9%	n/a
9995 RemeGen	HK$15.68	-12.4%	-41.6%	HK$14.2b	HK$24.08	PS4.6x	E56.4%	n/a
6826 Shanghai Haohai Biological Technology	HK$26.75	-1.7%	-9.2%	HK$13.5b	HK$42.55	PE13.6x	E20.1%	3.2%
6855 Ascentage Pharma Group International	HK$36.75	-4.5%	52.2%	HK$12.6b	HK$55.55	PS13x	E60.9%	n/a
6185 CanSino Biologics	HK$35.70	-5.9%	104.2%	HK$12.2b	HK$32.79	PS9.7x	E131.7%	0%